Regulations.gov document
Freedom of Information Summary NADA 200-534 Melengestrol acetate plus monensin USP plus…
Supporting & Related Material · FDA-2012-N-0002 · posted Jan 4, 2013
Key facts
| Document ID | FDA-2012-N-0002-0041 |
|---|---|
| Title | Freedom of Information Summary NADA 200-534 Melengestrol acetate plus monensin USP plus tylosin phosphate |
| Document type | Supporting & Related Material |
| Subtype | Freedom of Information Summary |
| Agency | FDA |
| Docket | FDA-2012-N-0002 |
| Posted | Jan 4, 2013 |
At a glance
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: